A man on X is speaking out against Cigna Healthcare after the medical insurance company denied his late wife coverage for a ...

Pancreatic cancer is widely known as one of the most dangerous and difficult cancers to treat. Among the different types of pancreatic cancer, the most common and aggressive form is called pancreatic ...

A Decision Score provides prognostic discrimination for 10-year locoregional recurrence, with rising score associated with ...

A personalized peptide vaccine slashed prostate-specific antigen levels by as much as 99.6% in some men with advanced ...

Circulating tumor DNA levels a few weeks after immunotherapy initiation could help identify patients with melanoma at greatest risk for recurrence or death.A retrospective analysis showed individuals ...

Neoadjuvant chemoimmunotherapy may beat immunotherapy alone when it comes to pathologic response, but its impact on survival remains to be seen.

A UT Dallas and UT Southwestern study found tumors in younger patients develop in scar-like colon tissue — changes that may occur before cancer forms. Getty Images Last month, actor James Van Der Beek ...

Engineers at Duke University have demonstrated a technique that uses microbubbles and ultrasound to help relatively large ...

For five decades, scientists have known about a notorious cancer-causing enzyme called SRC. But they always assumed it only appeared on the inside of cells, where it sent signals that fueled tumor ...

Head and neck squamous cell carcinomas (HNSCC) are the seventh-most prevalent form of cancer and are associated with human ...

An unexpected discovery may bring scientists closer to a long-sought goal: finding an ideal immunotherapy target for solid tumors.

Studies published by 20/20 Biolabs and several independent research groups in the U.S. and Asia over the past 10 months add to the growing body of evidence that our company’s patented multi-cancer ...